Market: The Emerging Prospects of Muscle Spasticity Therapeutics
Muscle Spasticity Market The Muscle Spasticity Therapeutics Market is estimated to be valued at US$ 4,167.6 million in 2023 and is expected to exhibit a CAGR of 8.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Muscle spasticity refers to stiffening or tightening of the muscles which occurs as a result of damage to the parts of the brain or spinal cord that control voluntary movement. It is commonly seen in conditions such as cerebral palsy, multiple sclerosis and spinal cord injuries. Several drugs and treatments are available to manage the symptoms of muscle spasticity including botulinum toxins, baclofen, dantrolene sodium and cannabinoids. Market Dynamics: The key drivers boosting growth of the muscle spasticity therapeutics market include rising prevalence of neurological disorders associated with muscle spasticity and increasing research & development activities. According to WHO, a...